JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 7, 2005; DOI: 10.1124/jpet.105.093898


0022-3565/06/3162-618-627$20.00
JPET 316:618-627, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.093898v1
316/2/618    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quiniou, C.
Right arrow Articles by Chemtob, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quiniou, C.
Right arrow Articles by Chemtob, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

CELLULAR AND MOLECULAR

Dominant Role for Calpain in Thromboxane-Induced Neuromicrovascular Endothelial Cytotoxicity

Christiane Quiniou, Florian Sennlaub, Martin H. Beauchamp, Daniella Checchin, Isabelle Lahaie, Sonia Brault, Fernand Gobeil, Jr., Mirna Sirinyan, Amna Kooli, Pierre Hardy, Alexey Pshezhetsky, and Sylvain Chemtob

Departments of Pediatrics and Pharmacology, Centre de Recherche de l'Hôpital Ste-Justine, Université de Montréal, Montréal, Québec, Canada (C.Q., F.S., M.H.B., D.C., I.L., S.B., F.G., M.S., A.K., P.H., A.P., S.C.); Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada (D.C., S.B., M.S., A.K., S.C.); Department of Biochemistry, Université de Montréal, Montréal, Québec, Canada (C.Q.); Department of Pharmacology, Université de Sherbrooke, Sherbrooke, Québec, Canada (F.G.); and Institut National de la Santé et Recherche Médicale, Unite 598, Paris, France (F.S.)

Thromboxane A2 (TXA2) is an important lipid mediator generated during oxidative stress and implicated in ischemic neural injury. This autacoid was recently shown to partake in this injury process by directly inducing endothelial cytotoxicity. We explored the mechanisms for this TXA2-evoked neural microvascular endothelial cell death. Stable TXA2 mimetics 5-heptenoic acid, 7-[6-(3-hydroxy-1-octenyl)-2-oxabicyclo[2.2.1]hept-5-yl]-[1R-[1{alpha},4{alpha},5beta(Z),6{alpha},(1E,3S)]]-9,11-dedioxy-9{alpha},11{alpha}-methanolpoxy (U-46619) [as well as [1S-[1{alpha},2{alpha}(Z),3beta(1E,3S*),4{alpha}]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo[2.1.1]-hept-2-yl]-5-heptenoic acid; I-BOP] induced a retinal microvascular degeneration in rat pups in vivo and in porcine retinal explants ex vivo and death of porcine brain endothelial cells (in culture). TXA2 dependence of these effects was corroborated by antagonism using the selective TXA2 receptor blocker (-)-6,8-difluoro-9-p-methyl-sulfonyl-benzyl-1,2,3,4-tetrahydrocarbazol-1-yl-acetic acid (L670596). In all cases, neurovascular endothelial cell death was prevented by pan-calpain and specific m-calpain inhibitors but not by caspase-3 or pan-caspase inhibitors. Correspondingly, TXA2 (mimetics) augmented generation of known active m-calpain (but not µ-calpain) form and increased the activity of m-calpain (cleavage of fluorogenic substrate N-succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin; and of {alpha}-spectrin into specific fragments) but not of pan-caspase or specific caspase-3 (respectively, using sulforhodamine-Val-Arg-Asp-fluoromethyl ketone and detecting its active 17- and 12-kDa fragments). Interestingly, these effects were phospholipase C (PLC)-dependent [associated with increase in inositol triphosphate and inhibited by PLC blocker 1-[6-[[17beta-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122 [GenBank] )] and required calcium but were not associated with increased intracellular calcium. U-46619-induced calpain activation resulted in translocation of Bax to the mitochondria, loss of polarization of the latter (using potentiometric probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine iodide; JC-1) and in turn release of cytochrome c into the cytosol and depletion of cellular ATP; these effects were all blocked by calpain inhibitors. Overall, this work identifies (specifically) m-calpain as a dominant protease in TXA2-induced neurovascular endothelial cell death.


Received August 9, 2005; accepted October 6, 2005.

Address correspondence to: Dr. Sylvain Chemtob, Department of Pediatrics, Ophthalmology, and Pharmacology, Research Centre, Ste-Justine Hospital, 3175 Cote Ste-Catherine Montreal, Quebec H3T 1C5, Canada. E-mail: sylvain.chemtob{at}umontreal.ca




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Brault, F. Gobeil Jr., A. Fortier, J.-C. Honore, J.-S. Joyal, P. S. Sapieha, A. Kooli, E. Martin, P. Hardy, A. Ribeiro-da-Silva, et al.
Lysophosphatidic acid induces endothelial cell death by modulating the redox environment
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1174 - R1183.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.